Lingbing Zhang

Verified @outlook.com

Department of Pharmacy
The First Afliated Hospital of Chongqing Medical University

EDUCATION

Chongqing Medical University, Chongqing, China Sept 2019 - June 2022
Master of Science in Clinical Pharmacy,
Zunyi Medical University, Guizhou, China Sept 2014 - June 2019
Bachelor of Science in Clinical Pharmacy,

RESEARCH INTERESTS

My research direction was mainly the mechanism of lung injury and brain damage, with the methodology of molecular biology and animal experiment.

RESEARCH OUTPUTS (PATENTS, SOFTWARE, PUBLICATIONS, PRODUCTS)

Zhang L, Zhang Y, Qin X, Jiang X, Zhang J, Mao L, Jiang Z, Jiang Y, Liu G, Qiu J, Chen C, Qiu F, Zou Z, Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein, Critical Care (2022), IF: 19.334, Rank: Q1 5/36

Zhang L, Zhang Y, Jiang X, Mao L, Xia Y, Fan Y, Li N, Jiang Z, Qin X, Jiang Y, Liu G, Qiu F, Zhang J, Zou Z, Chen C,
Disruption of lung-gut-brain axis is responsible for cortex injury induced by pulmonary exposure to zinc oxide nanoparticles, Toxicology (2023), IF: 4.571, Rank: Q2 76/261

Zhang Y, Zhang L, Mao L, Fan J, Jiang X, Li N, Fan Y, Jiang Z, Qin X, Qiu F, Jiang Y, Liu G, Zhang J, Chen C, Zou Z, Intestinal Microbiota-derived Propionic Acid Protects against Zinc Oxide Nanoparticle-induced Lung Injury, American Journal of Respiratory Cell and Molecular Biology (2022), IF:7.748, Rank: Q1 53/295

Man X, Cao L, Meng Z, Wang M, Ye L, Zhang L, Detection of Caffeine in Tea Made by Simulating Daily Drinking Manner, Yunnan Chemical Technology (2018): 02